Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Lung & Bronchus (Late Stage^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count ascending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 39.0 (38.9, 39.0) N/A 152,236 68.3
California 3 *** 27.9 (27.6, 28.1) 45 (44, 47) 11,803 69.4
Florida 6 *** 38.2 (37.9, 38.5) 31 (28, 32) 11,575 66.7
New York 3 *** 38.5 (38.2, 38.9) 30 (26, 32) 9,359 66.5
Texas 6 *** 32.2 (31.9, 32.5) 42 (41, 42) 8,864 65.9
Pennsylvania 6 *** 43.2 (42.8, 43.7) 19 (15, 22) 7,524 69.0
Ohio 6 *** 46.1 (45.6, 46.6) 11 (10, 13) 6,905 68.6
Illinois 6 *** 43.5 (43.0, 44.0) 18 (15, 21) 6,607 69.3
North Carolina 6 *** 46.8 (46.2, 47.3) 10 (9, 12) 5,851 70.9
Michigan 5 *** 43.6 (43.1, 44.1) 17 (14, 21) 5,619 69.6
Georgia 3 *** 44.5 (44.0, 45.1) 14 (13, 17) 5,003 73.4
Tennessee 6 *** 50.6 (49.9, 51.3) 5 (4, 7) 4,222 68.7
New Jersey 3 *** 36.5 (36.0, 37.0) 34 (32, 36) 4,016 67.2
Indiana 6 *** 50.3 (49.6, 51.0) 6 (4, 7) 4,007 72.1
Missouri 6 *** 47.8 (47.1, 48.5) 8 (8, 10) 3,717 67.8
Virginia 6 *** 37.2 (36.7, 37.8) 33 (31, 35) 3,714 68.5
Kentucky 3 *** 64.4 (63.4, 65.4) 1 (1, 1) 3,577 72.8
Wisconsin 6 *** 41.7 (41.0, 42.4) 23 (20, 26) 3,081 71.2
Washington 5 *** 35.1 (34.5, 35.6) 38 (36, 40) 2,983 67.1
South Carolina 6 *** 42.4 (41.7, 43.1) 22 (18, 24) 2,757 67.8
Louisiana 3 *** 47.8 (47.0, 48.6) 9 (7, 10) 2,631 74.4
Alabama 6 *** 41.4 (40.6, 42.1) 24 (21, 26) 2,596 65.4
Maryland 6 *** 36.3 (35.7, 36.9) 35 (32, 37) 2,582 66.2
Arizona 6 *** 27.7 (27.2, 28.2) 46 (44, 48) 2,446 61.6
Minnesota 6 *** 35.6 (35.0, 36.3) 36 (34, 39) 2,375 64.8
Oklahoma 6 *** 44.0 (43.1, 44.9) 15 (13, 21) 2,071 66.3
Arkansas 6 *** 51.6 (50.6, 52.7) 4 (3, 7) 1,970 67.6
Mississippi 6 *** 53.2 (52.1, 54.3) 3 (3, 4) 1,924 72.1
Iowa 3 *** 45.9 (45.0, 46.9) 12 (10, 14) 1,834 73.3
Oregon 6 *** 34.7 (33.9, 35.4) 39 (36, 40) 1,822 66.2
Connecticut 3 *** 38.9 (38.1, 39.7) 27 (25, 32) 1,816 67.5
Colorado 6 *** 26.7 (26.1, 27.4) 48 (46, 48) 1,591 66.9
West Virginia 6 *** 56.6 (55.3, 57.9) 2 (2, 2) 1,499 71.7
Kansas 6 *** 38.8 (37.9, 39.8) 28 (25, 32) 1,342 70.0
Maine 6 *** 50.2 (48.7, 51.6) 7 (4, 8) 996 70.5
Nebraska 6 *** 37.5 (36.4, 38.7) 32 (27, 36) 846 67.2
Nevada 6 *** 30.6 (29.7, 31.6) 43 (42, 44) 835 60.2
New Hampshire 6 *** 43.2 (41.8, 44.6) 20 (13, 25) 790 69.5
Idaho 3 *** 34.0 (32.8, 35.2) 40 (36, 41) 667 69.5
Rhode Island 6 *** 45.4 (43.8, 47.1) 13 (8, 20) 621 66.0
Hawaii 3 *** 32.5 (31.4, 33.8) 41 (40, 43) 607 73.5
New Mexico 3 *** 22.4 (21.6, 23.2) 49 (49, 49) 595 61.1
Delaware 6 *** 43.8 (42.2, 45.5) 16 (11, 24) 565 67.8
Montana 6 *** 35.4 (34.0, 36.8) 37 (32, 40) 504 69.4
Utah 3 *** 18.7 (18.0, 19.5) 50 (50, 50) 488 72.3
South Dakota 6 *** 40.0 (38.3, 41.8) 26 (21, 32) 427 69.8
Vermont 6 *** 42.5 (40.5, 44.6) 21 (13, 26) 372 70.5
North Dakota 6 *** 40.8 (38.8, 42.8) 25 (17, 31) 352 70.6
Puerto Rico 6 *** 6.8 (6.5, 7.2) N/A 327 42.4
Alaska 6 *** 38.6 (36.3, 40.9) 29 (22, 37) 259 70.8
District of Columbia 6 *** 28.8 (27.0, 30.7) 44 (43, 48) 192 63.9
Wyoming 6 *** 27.0 (25.3, 28.9) 47 (44, 48) 190 64.7
Massachusetts 3 ***
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 09/25/2022 7:06 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Massachusetts

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top